Assessing factor consumption and bleeding outcomes of prophylaxis with 3 commonly prescribed factor IX products for hemophilia B: A retrospective patient medical record analysis in the United States. [PDF]
J Manag Care Spec PharmEscobar M +7 more
europepmc +1 more source
Second gene therapy for hemophilia B approved: More answers or questions? [PDF]
Mol TherKaczmarek R, Pierce GF.
europepmc +1 more source
Hepatitis C infection in children with hemophilia A and B [PDF]
, 1991 V. Blanchette +6 more
openalex +1 more source
Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years. [PDF]
Blood Advvon Drygalski A +11 more
europepmc +1 more source
Plasma levels of Human Granulocytic Elastase-alpha-Proteinase Inhibitor Complex (E-alpha1PI) in Leukemia [PDF]
, 1984 Hiller, E., Jochum, Marianne
core
Hemophilia B Durham: a mutation in the first EGF-like domain of factor IX that is characterized by polymerase chain reaction [PDF]
, 1988 PH Denton +3 more
openalex +1 more source
Identification of Novel <i>F9</i> Gene Variants in 143 Vietnamese Patients with Hemophilia B. [PDF]
J Blood MedBach KQ +10 more
europepmc +1 more source
958. A Novel Approach to Proliferate Factor IX-Producing Hepatocytes Using Urokinase-Type Plasminogen Activator Transgenic SCID Mice for Establishment of Cell-Based Therapy of Hemophilia B [PDF]
, 2007 openalex +1 more source
Some MSM Blood Donors Move from a Lifetime Deferral to a One Year Ban “Finally” or “Not Good Enough”? [PDF]
, 2018 Printz, Heather
core +1 more source
The Indian Experience With Nonacog Beta Pegol for the Treatment of Hemophilia B in Children and Adolescents: A Safety and Efficacy Evaluation. [PDF]
CureusPatel N +5 more
europepmc +1 more source